| Model Number |
DVFB1D1 |
| Medical Device Problem Codes |
Pacing Problem (1439); Device Sensing Problem (2917)
|
| Health Effect - Clinical Code |
Ventricular Fibrillation (2130)
|
| Date of Event |
08/24/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the implantable cardioverter defibrillator (icd) supra ventricular tachycardia (svt) discriminator possibly delayed detection and anti-tachycardia pacing (atp) therapy for ventricular fibrillation (vf).It was also noted there was undersensing on the right ventricular (rv) lead.The device and lead remain in use.No further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was further reported that the supra ventricular tachycardia (svt) was accelerated to ventricular fibrillation (vf) due to anti-tachycardia pacing (atp) therapy.
|
| |
|
Search Alerts/Recalls
|